Dexin Yu Selected Research

Iron

3/2024	pH-responsive iron-loaded carbonaceous nanoparticles for chemodynamic therapy based on the Fenton reaction.
1/2017	pH-Responsive, Self-Sacrificial Nanotheranostic Agent for Potential In Vivo and In Vitro Dual Modal MRI/CT Imaging, Real-Time, and In Situ Monitoring of Cancer Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dexin Yu Research Topics

Disease

44	Neoplasms (Cancer) 04/2024 - 02/2006
17	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 09/2015
6	Neoplasm Metastasis (Metastasis) 12/2023 - 02/2006
6	Kidney Neoplasms (Kidney Cancer) 01/2023 - 03/2018
5	Carcinoma (Carcinomatosis) 01/2022 - 06/2008
4	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 11/2014
4	Carcinogenesis 02/2021 - 01/2017
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 07/2015
3	Breast Neoplasms (Breast Cancer) 12/2023 - 02/2018
3	Adenocarcinoma 03/2023 - 11/2021
3	Hepatocellular Carcinoma (Hepatoma) 04/2015 - 08/2011
2	Pathologic Constriction (Stenosis) 02/2023 - 04/2021
2	Pain (Aches) 11/2022 - 01/2022
2	Reperfusion Injury 05/2022 - 01/2022
2	Infections 01/2022 - 04/2021
2	Urinary Calculi (Urinary Calculus) 01/2022 - 04/2021
2	Pathologic Dilatation (Ectasia) 02/2018 - 01/2015
1	Hypoxia (Hypoxemia) 01/2024
1	Inflammation (Inflammations) 12/2023
1	Hypertension (High Blood Pressure) 11/2023
1	Overweight 10/2023
1	Hyperlipidemias (Hyperlipidemia) 08/2023
1	Non-alcoholic Fatty Liver Disease 08/2023
1	Fatty Liver 08/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2023
1	Margins of Excision 12/2022
1	Hemospermia 11/2022
1	Splenic Rupture 11/2022
1	Acute Kidney Injury (Acute Renal Failure) 05/2022
1	Ischemia 05/2022
1	Vitamin D Deficiency 05/2022

Drug/Important Bio-Agent (IBA)

10	SmokeIBA 11/2020 - 09/2015
8	Proteins (Proteins, Gene)FDA Link 03/2023 - 02/2017
6	Contrast MediaIBA 03/2017 - 08/2011
5	Gadolinium DTPA (Magnevist)FDA Link 01/2017 - 03/2009
4	Biomarkers (Surrogate Marker)IBA 12/2023 - 05/2021
4	benzidineIBA 02/2021 - 04/2017
4	AcidsIBA 01/2017 - 11/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 01/2017
3	IonsIBA 03/2024 - 01/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 06/2008
3	CurcuminIBA 01/2020 - 04/2017
3	GadoliniumIBA 05/2013 - 03/2009
2	IronIBA 03/2024 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2024 - 01/2021
2	AndrogensIBA 03/2022 - 12/2017
2	ResveratrolIBA 01/2021 - 01/2019
2	Mitogen-Activated Protein KinasesIBA 01/2020 - 02/2017
2	Folic Acid (Vitamin M)FDA LinkGeneric 10/2019 - 01/2017
2	3,4-methylenedioxyethamphetamine (MDEA)IBA 02/2018 - 01/2015
2	Protein Kinases (Protein Kinase)IBA 04/2017 - 02/2017
2	Lysine (L-Lysine)FDA Link 03/2017 - 01/2017
2	Pentetic Acid (DTPA)FDA LinkGeneric 01/2017 - 08/2011
2	SolutionsIBA 05/2016 - 03/2014
2	ChitosanIBA 08/2015 - 05/2013
1	manganese dioxideIBA 01/2024
1	Peroxidase (Myeloperoxidase)IBA 01/2024
1	arginyl-glycyl-aspartic acidIBA 01/2024
1	LigandsIBA 01/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024
1	Hemoglobins (Hemoglobin)IBA 11/2023
1	Cystatin CIBA 11/2023
1	Hormones (Hormone)IBA 10/2023
1	LipidsIBA 08/2023
1	thymoquinoneIBA 08/2023
1	oxidized low density lipoproteinIBA 08/2023
1	Transforming Growth Factor-beta Type I ReceptorIBA 03/2023
1	Androgen Receptors (Androgen Receptor)IBA 03/2023
1	Origin Recognition ComplexIBA 03/2023
1	DNA (Deoxyribonucleic Acid)IBA 03/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	camrelizumabIBA 01/2023
1	Angiogenesis InhibitorsIBA 01/2023
1	diallyl trisulfideIBA 01/2023
1	apatinibIBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Cholecalciferol (Vitamin D3)FDA Link 05/2022
1	CytokinesIBA 05/2022
1	Interleukin-18 (Interleukin 18)IBA 05/2022
1	enzalutamideIBA 03/2022
1	Circular RNAIBA 03/2022
1	MicroRNAs (MicroRNA)IBA 03/2022

Therapy/Procedure

19	Therapeutics 03/2024 - 02/2006
6	Drug Therapy (Chemotherapy) 01/2024 - 10/2019
5	Precision Medicine 01/2024 - 03/2014
5	Nephrectomy 01/2022 - 07/2015
3	Immunotherapy 04/2024 - 01/2023
3	Photothermal Therapy 01/2023 - 10/2014
3	Lasers (Laser) 12/2020 - 10/2014
2	Operative Time 02/2023 - 11/2021
2	Urinary Diversion (Ileal Conduit) 11/2021 - 04/2021
1	Stents 12/2023
1	Gastrectomy 10/2023
1	Bariatric Surgery 10/2023
1	Neoadjuvant Therapy 01/2023
1	Hepatectomy 12/2022
1	Splenectomy 11/2022
1	Castration 03/2022